Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sterify Gel is a bioactive topical gel developed as an adjunct to standard non-surgical therapy for the treatment of peri-implantitis. The formulation is a multi-component mixture containing polyvinyl polymers, hydroxytyrosol (a potent antioxidant), magnesium ascorbyl phosphate (a stable vitamin C derivative), and nisin (an antimicrobial peptide). The gel is designed to be applied topically to the tissues around dental implants to reduce inflammation, manage plaque levels, and improve clinical outcomes such as bleeding on probing and probing depth. It functions by providing antimicrobial activity against oral pathogens and exerting antioxidant effects to mitigate oxidative stress and promote tissue healing in the peri-implant environment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sterify Gel (Sterify).